• European session review: USD weakens as investors cheer a potential COVID-19 treatment breakthrough, while awaiting the Fed's Jackson Hole Symposium

Market news

24 August 2020

European session review: USD weakens as investors cheer a potential COVID-19 treatment breakthrough, while awaiting the Fed's Jackson Hole Symposium

USD  fell against its major rivals in the European session on Monday as hopes for a coronavirus treatment breakthrough bolstered risk appetite, while market participants waited for the Fed’s annual Jackson Hole Symposium. The U.S. Dollar Index (DXY), measuring the U.S. currency's value relative to a basket of foreign currencies, dropped 0.39% to 92.88.

The U.S. Food and Drug Administration (FDA) issued an "emergency use authorization" for convalescent plasma as a treatment of Covid-19 in hospitalized patients. According to the FDA, early evidence indicated that the antibody-rich plasma "may be effective" in treating Covid-19. “This is a powerful therapy,” the U.S. President Donald Trump stated on Sunday at a White House news conference. “Today’s action will dramatically expand access to this treatment.” The Financial Times reported that the Trump administration is considering "fast-tracking" the Covid-19 vaccine candidate being developed by AstraZeneca and Oxford University.

Investors also looked ahead to the U.S. Federal Reserve's annual Jackson Hole meeting later in the week, where its Chair Jerome Powell will discuss the U.S. monetary policy.


Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Open Demo Account & Personal Page
I understand and accept the Privacy Policy and agree to my name and contact details being used by TeleTrade to contact me about this.